0001623526 2026-07-31 2026-07-31 0001623526 1 2026-07-31 2026-07-31 iso4217:USD pure S-3 424B5 EX-FILING FEES 333-294402 0001623526 Stoke Therapeutics, Inc. N/A N/A S-3 Stoke Therapeutics, Inc. false Equity Common Stock, par value $0.0001 per share true 200000000.00 0.0001381 27620.00 200000000.00 27620.00 0.00 0.00 27620.00 Consists of shares to be issued pursuant to that certain Controlled Equity Offering Sales Agreement, dated as of May 20, 2022, between the registrant and Cantor Fitzgerald & Co. The proposed maximum aggregate offering price is being used to calculate the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the "Securities Act"). The fee is calculated in accordance with Rule 456(b) and Rule 457(r) of the Securities Act. 200000000.00 true